A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Ulcerative Colitis
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Ulcerative Colitis
The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in ulcerative colitis (UC).
Key Inclusion Criteria:
Key Exclusion Criteria:
NOTE: Other protocol defined Inclusion/ Exclusion criteria may apply.
Boston, Massachusetts 02114, United States
Clayton, New South Wales 3168, Australia
Hamilton, Ontario L8S 4K1, Canada
Mladá Boleslav, 293 01, Czechia
Prague, 190 00, Czechia
Athens, 11527, Greece
Shatin, Hong Kong
Békéscsaba, 5600, Hungary
Budapest, 1097, Hungary
Budapest, 1125, Hungary
Debrecen, 4032, Hungary
Mosonmagyaróvár, 9200, Hungary
Milan, 20121, Italy
Jonan-ku, 814-0180, Japan
Kitakyushu-shi, 802-0077, Japan
Kurume-shi, 830-0011, Japan
Kurume-shi, 839-0809, Japan
Mitaka-shi, 181-8611, Japan
Nagakute-shi, 480-1195, Japan
Shinjuku-ku, 169-0073, Japan
Takasaki-shi, 3700829, Japan
Toyota-shi, 470-1219, Japan
Bialystok, 15-276, Poland
Poznan, 60-848, Poland
Torun, 87-100, Poland
Warsaw, 02-507, Poland
Bucharest, 020125, Romania
Chelyabinsk, 454076, Russia
Irkutsk, 669079, Russia
Moscow, 115446, Russia
Moscow, 127015, Russia
Moscow, 129110, Russia
Nizhny Novgorod, 603126, Russia
Novosibirsk, 630084, Russia
Novosibirsk, 630087, Russia
Saint Petersburg, 191015, Russia
Tyumen, 625026, Russia
Seoul, 06351, South Korea
Cherkasy, 18000, Ukraine
Chernivtsi, 58000, Ukraine
Chernivtsi, 58000, Ukraine
Dnipropetrovsk, 49000, Ukraine
Ivano-Frankivsk, 76018, Ukraine
Kharkiv, 61037, Ukraine
Kharkiv, 61039, Ukraine
Kharkiv, 63101, Ukraine
Kyiv, 1103, Ukraine
Odesa, 65010, Ukraine
Odesa, 65025, Ukraine
Ternopil, 46002, Ukraine
Vinnytsia, 21005, Ukraine
Vinnytsia, 21018, Ukraine
Zaporizhzhya, 69600, Ukraine
Norwich, Norfolk NR4 7UY, United Kingdom
Glasgow, G51 4TF, United Kingdom